Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study

Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study

Abstract Background In the REMoxTB study of 4-month treatment-shortening regimens containing moxifloxacin compared to the standard 6-month regimen for tuberculosis, the proportion of unfavourable outcomes for women was similar in all study arms, but men had more frequent unfavourable outcomes (bacte...

Full description

Bibliographic Details
Main Authors: M. E. Murphy, G. H. Wills, S. Murthy, C. Louw, A. L. C. Bateson, R. D. Hunt, T. D. McHugh, A. J. Nunn, S. K. Meredith, C. M. Mendel, M. Spigelman, A. M. Crook, S. H. Gillespie, for the REMoxTB consortium
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Medicine
Subjects:
Gender
Tuberculosis
Treatment outcome
Cavitation
Clinical trials
REMoxTB
Online Access:http://link.springer.com/article/10.1186/s12916-018-1169-5

Internet

http://link.springer.com/article/10.1186/s12916-018-1169-5

Similar Items